{"transactions":[{"id":729573,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:51:01.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":18880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18880},"source":{"system":"sec-edgar","filing":"0001104659-26-076924","document":"tm2618639-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076924/tm2618639-3_4seq1.xml","form_type":"4"}},{"id":729572,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:51:01.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":14180,"derivative":{"underlying":"Common Stock","underlying_shares":14180},"source":{"system":"sec-edgar","filing":"0001104659-26-076924","document":"tm2618639-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076924/tm2618639-3_4seq1.xml","form_type":"4"}},{"id":729571,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T23:51:01.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":21270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":21270,"derivative":{"exercise_price":9.13,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":21270},"source":{"system":"sec-edgar","filing":"0001104659-26-076924","document":"tm2618639-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076924/tm2618639-3_4seq1.xml","form_type":"4"}},{"id":729570,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T23:51:01.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":18880,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":47685,"source":{"system":"sec-edgar","filing":"0001104659-26-076924","document":"tm2618639-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076924/tm2618639-3_4seq1.xml","form_type":"4"}},{"id":764434,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-26T21:39:56.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date."}],"balance_after":12500,"derivative":{"exercise_price":59.69,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001193125-26-239714","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526239714/ownership.xml","form_type":"4"}},{"id":1103159,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:36:57.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":18884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":18884,"derivative":{"underlying":"Common Stock","underlying_shares":18884},"source":{"system":"sec-edgar","filing":"0001104659-25-062192","document":"tm2518838-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062192/tm2518838-2_4seq1.xml","form_type":"4"}},{"id":1103158,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:36:57.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":28326,"price":6.42,"value":181852.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":28326,"derivative":{"exercise_price":6.42,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":28326},"source":{"system":"sec-edgar","filing":"0001104659-25-062192","document":"tm2518838-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062192/tm2518838-2_4seq1.xml","form_type":"4"}},{"id":1110363,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-16T20:09:43.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":false,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-25-000783","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000783/primary_01.xml","form_type":"4"}},{"id":1110362,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-16T20:09:43.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28805,"source":{"system":"sec-edgar","filing":"0001593968-25-000783","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000783/primary_01.xml","form_type":"4"}},{"id":1114077,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-06-13T00:40:50.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of June 10, 2025 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date."}],"balance_after":15000,"derivative":{"exercise_price":72.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-25-085754","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017025085754/ownership.xml","form_type":"4"}},{"id":1282656,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:06:02.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":1982,"price":8.61,"value":17065.02,"ownership":{"direct":true},"balance_after":18385,"source":{"system":"sec-edgar","filing":"0001104659-25-009786","document":"tm255659-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009786/tm255659-2_4seq1.xml","form_type":"4"}},{"id":1282655,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:06:02.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":1311,"price":12.77,"value":16741.47,"ownership":{"direct":true},"balance_after":16403,"source":{"system":"sec-edgar","filing":"0001104659-25-009786","document":"tm255659-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009786/tm255659-2_4seq1.xml","form_type":"4"}},{"id":1282654,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:06:02.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":1202,"price":13.93,"value":16743.86,"ownership":{"direct":true},"balance_after":15092,"source":{"system":"sec-edgar","filing":"0001104659-25-009786","document":"tm255659-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009786/tm255659-2_4seq1.xml","form_type":"4"}},{"id":1282653,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T00:06:02.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":3420,"price":4.9,"value":16758.0,"ownership":{"direct":true},"balance_after":7220,"source":{"system":"sec-edgar","filing":"0001104659-25-009786","document":"tm255659-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925009786/tm255659-2_4seq1.xml","form_type":"4"}},{"id":1468001,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-06-27T22:53:05.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":48137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48137,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":48137},"source":{"system":"sec-edgar","filing":"0001731122-24-001031","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112224001031/ownership.xml","form_type":"4"}},{"id":1479733,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:11:42.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10420,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-24-000864","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000864/primary_01.xml","form_type":"4"}},{"id":1479732,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:11:42.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":15.86,"value":247891.8,"ownership":{"direct":true},"balance_after":15630,"derivative":{"exercise_price":15.86,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0001593968-24-000864","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000864/primary_01.xml","form_type":"4"}},{"id":1479731,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:11:42.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":false,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001593968-24-000864","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000864/primary_01.xml","form_type":"4"}},{"id":1479730,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:11:42.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10470,"source":{"system":"sec-edgar","filing":"0001593968-24-000864","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000864/primary_01.xml","form_type":"4"}},{"id":1507603,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-21T22:30:14.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 17, 2024 over a one-year period."}],"balance_after":30000,"derivative":{"exercise_price":28.09,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-063166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000095017024063166/ownership.xml","form_type":"4"}},{"id":1661093,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-02-02T17:14:37.000Z","date":"2023-12-27","kind":"grant","planned":false,"acquired":true,"shares":23810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23810,"derivative":{"exercise_price":3.15,"exercise_date":"2024-12-27","expiration_date":"2033-12-27","underlying":"Common stock","underlying_shares":23810},"source":{"system":"sec-edgar","filing":"0001731122-24-000185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112224000185/ownership.xml","form_type":"4"}},{"id":1857746,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:43:20.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":6670,"derivative":{"underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001209191-23-036741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036741/doc4.xml","form_type":"4"}},{"id":1857745,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T20:43:20.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to this option grant under the the Plan will vest one (1) year from the June 12, 2023 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7710,"derivative":{"exercise_price":7.78,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":7710},"source":{"system":"sec-edgar","filing":"0001209191-23-036741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036741/doc4.xml","form_type":"4"}},{"id":1857744,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:43:20.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":false,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001209191-23-036741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036741/doc4.xml","form_type":"4"}},{"id":1857743,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T20:43:20.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":true,"shares":3100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-23-036741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036741/doc4.xml","form_type":"4"}},{"id":1881516,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-23T21:00:40.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 19, 2023 over a one-year period."}],"balance_after":30000,"derivative":{"exercise_price":24.1,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-013739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924323013739/doc4.xml","form_type":"4"}},{"id":2061954,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2023-01-05T21:48:48.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":57252,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57252,"derivative":{"exercise_price":1.31,"exercise_date":"2023-12-27","expiration_date":"2032-12-27","underlying":"Common stock","underlying_shares":57252},"source":{"system":"sec-edgar","filing":"0001731122-23-000021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112223000021/ownership.xml","form_type":"4"}},{"id":2226046,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-22T00:45:13.000Z","date":"2022-06-17","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-22-038590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038590/doc4.xml","form_type":"4"}},{"id":2226045,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T00:45:13.000Z","date":"2022-06-17","kind":"exercise","acquired":true,"shares":700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001209191-22-038590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038590/doc4.xml","form_type":"4"}},{"id":2233198,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-14T21:06:24.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":3100,"derivative":{"underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001209191-22-036745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036745/doc4.xml","form_type":"4"}},{"id":2233197,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T21:06:24.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 10, 2022 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":4600,"derivative":{"exercise_price":40.62,"exercise_date":"2023-06-10","expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001209191-22-036745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036745/doc4.xml","form_type":"4"}},{"id":2248081,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-06-02T21:00:48.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 31, 2022 over a one-year period."}],"balance_after":20000,"derivative":{"exercise_price":20.84,"expiration_date":"2032-05-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-22-020701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924322020701/doc4.xml","form_type":"4"}},{"id":2457779,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2021-12-29T02:41:37.000Z","date":"2021-12-27","kind":"grant","acquired":true,"shares":9458,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9458,"derivative":{"exercise_price":7.93,"exercise_date":"2022-12-27","expiration_date":"2031-12-27","underlying":"Common stock","underlying_shares":9458},"source":{"system":"sec-edgar","filing":"0001731122-21-002209","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112221002209/ownership.xml","form_type":"4"}},{"id":2460674,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2021-12-22T16:10:49.000Z","date":"2020-04-06","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On April 6, 2020, Mr. Alton was granted an option to purchase 15,625 shares of common stock of Enochian Biosciences Inc., said option to vest on December 27, 2020."}],"balance_after":15625,"derivative":{"exercise_price":4.8,"exercise_date":"2020-12-27","expiration_date":"2030-04-06","underlying":"Common stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001731122-21-002176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112221002176/ownership.xml","form_type":"4"}},{"id":2460673,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2021-12-22T16:10:49.000Z","date":"2020-12-28","kind":"grant","acquired":true,"shares":25424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 3, 2020, Mr. Alton was granted an option to purchase 25,424 shares of common stock of Enochian Biosciences Inc., said option to vest on December 28, 2021."}],"balance_after":25424,"derivative":{"exercise_price":2.95,"exercise_date":"2021-12-28","expiration_date":"2030-12-28","underlying":"Common stock","underlying_shares":25.424},"source":{"system":"sec-edgar","filing":"0001731122-21-002176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112221002176/ownership.xml","form_type":"4"}},{"id":2659494,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-22T21:15:08.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":700,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-21-042449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042449/doc4.xml","form_type":"4"}},{"id":2659493,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:15:08.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 17, 2021 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":1300,"derivative":{"exercise_price":179.89,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001209191-21-042449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042449/doc4.xml","form_type":"4"}},{"id":2691835,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-28T21:15:20.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 26, 2021 over a one-year period."}],"balance_after":20000,"derivative":{"exercise_price":21.45,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-021144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924321021144/doc4.xml","form_type":"4"}},{"id":2995458,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-03T23:15:49.000Z","date":"2020-10-31","kind":"grant","acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the October 31, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7700,"derivative":{"exercise_price":80.71,"exercise_date":"2021-10-31","expiration_date":"2030-10-31","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001209191-20-056737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120056737/doc4.xml","form_type":"4"}},{"id":3131107,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-29T23:22:28.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over a one-year period."}],"balance_after":30000,"derivative":{"exercise_price":15.15,"expiration_date":"2030-05-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-014627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924320014627/doc4.xml","form_type":"4"}},{"id":3211682,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-13T22:00:52.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the stock option vest and become exercisable with respect to 25% of the shares on the first anniversary of the date of grant and, thereafter, at the rate of 2.08334% of the total number of shares per month, until fully vested and exercisable on the fourth anniversary of the date of grant, subject to the Reporting Person's continued service."}],"balance_after":60000,"derivative":{"exercise_price":10.48,"expiration_date":"2030-03-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-008294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000089924320008294/doc4.xml","form_type":"4"}},{"id":406243,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"Chief Patient Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-03-06T00:48:39.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":1890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":15530,"derivative":{"underlying":"Common Stock","underlying_shares":1890},"source":{"system":"sec-edgar","filing":"0001127602-19-010115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219010115/form4.xml","form_type":"4"}},{"id":406242,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"Chief Patient Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-03-06T00:48:39.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":9640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":9640,"derivative":{"exercise_price":66.01,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":9640},"source":{"system":"sec-edgar","filing":"0001127602-19-010115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219010115/form4.xml","form_type":"4"}},{"id":406241,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2019-03-06T00:48:39.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":330,"price":57.4515,"value":18958.995,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":58046,"source":{"system":"sec-edgar","filing":"0001127602-19-010115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219010115/form4.xml","form_type":"4"}},{"id":408187,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Restricted Stock Unit","published_at":"2019-02-08T23:01:44.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":13640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested."}],"balance_after":13640,"derivative":{"underlying":"Common Stock","underlying_shares":13640},"source":{"system":"sec-edgar","filing":"0001127602-19-004871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004871/form4.xml","form_type":"4"}},{"id":408186,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-02-08T23:01:44.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":63100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":63100,"derivative":{"exercise_price":68.75,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":63100},"source":{"system":"sec-edgar","filing":"0001127602-19-004871","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004871/form4.xml","form_type":"4"}},{"id":408185,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2019-02-08T23:01:44.000Z","date":"2019-02-06","kind":"tax_withholding","acquired":false,"shares":5861,"price":68.75,"value":402943.75,"ownership":{"direct":true},"balance_after":57716,"source":{"system":"sec-edgar","filing":"0001127602-19-004871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004871/form4.xml","form_type":"4"}},{"id":408184,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2019-02-08T23:01:44.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":9042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":63577,"source":{"system":"sec-edgar","filing":"0001127602-19-004871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004871/form4.xml","form_type":"4"}},{"id":408183,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2019-02-08T23:01:44.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":10109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 2, 2017, and February 1, 2018. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":54535,"source":{"system":"sec-edgar","filing":"0001127602-19-004871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004871/form4.xml","form_type":"4"}},{"id":417419,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-03-06T00:04:28.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":55596,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001127602-18-010234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010234/form4.xml","form_type":"4"}},{"id":417418,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-03-06T00:04:28.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":3099,"price":79.4116,"value":246096.5484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $79.22 to $79.66.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":44426,"source":{"system":"sec-edgar","filing":"0001127602-18-010234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010234/form4.xml","form_type":"4"}},{"id":417417,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-03-06T00:04:28.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":16200,"price":78.9244,"value":1278575.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $78.21 to $79.21.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":47525,"source":{"system":"sec-edgar","filing":"0001127602-18-010234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010234/form4.xml","form_type":"4"}},{"id":417416,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-03-06T00:04:28.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":5701,"price":77.643,"value":442642.743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $77.17 to $78.14.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":63725,"source":{"system":"sec-edgar","filing":"0001127602-18-010234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010234/form4.xml","form_type":"4"}},{"id":417415,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-03-06T00:04:28.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":17250,"price":40.56,"value":699660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":69426,"source":{"system":"sec-edgar","filing":"0001127602-18-010234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010234/form4.xml","form_type":"4"}},{"id":418269,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-24T00:17:24.000Z","date":"2018-02-21","kind":"tax_withholding","acquired":false,"shares":5894,"price":80.69,"value":475586.86,"ownership":{"direct":true},"balance_after":52176,"source":{"system":"sec-edgar","filing":"0001127602-18-008148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008148/form4.xml","form_type":"4"}},{"id":418268,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-24T00:17:24.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":5672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2015. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":58070,"source":{"system":"sec-edgar","filing":"0001127602-18-008148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008148/form4.xml","form_type":"4"}},{"id":418267,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-24T00:17:24.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":14320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2016, and February 2, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2018 and December 31, 2019, respectively."}],"balance_after":52398,"source":{"system":"sec-edgar","filing":"0001127602-18-008148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008148/form4.xml","form_type":"4"}},{"id":418266,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-24T00:17:24.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":340,"price":62.3475,"value":21198.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":38078,"source":{"system":"sec-edgar","filing":"0001127602-18-008148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008148/form4.xml","form_type":"4"}},{"id":418596,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-21T23:51:59.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":14435,"price":81.5374,"value":1176992.369,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open Market Sale of Family Trust Shares"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $81.4601 to $81.60.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-18-007629","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218007629/form4.xml","form_type":"4"}},{"id":419004,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-17T00:32:54.000Z","date":"2017-01-20","kind":"other","acquired":true,"shares":14435,"price":71.01,"value":1025029.35,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares inherited from family trust"}],"balance_after":14435,"source":{"system":"sec-edgar","filing":"0001127602-18-006856","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218006856/form5.xml","form_type":"5"}},{"id":419635,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-02-06T02:20:41.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":62910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":62910,"derivative":{"exercise_price":83.49,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":62910},"source":{"system":"sec-edgar","filing":"0001127602-18-004188","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004188/form4.xml","form_type":"4"}},{"id":419634,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-02-06T02:20:41.000Z","date":"2018-02-01","kind":"exercise","acquired":false,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":72846,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001127602-18-004188","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004188/form4.xml","form_type":"4"}},{"id":419633,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-06T02:20:41.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":15214,"price":83.6601,"value":1272804.7614,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $83.49 to $84.04.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":37738,"source":{"system":"sec-edgar","filing":"0001127602-18-004188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004188/form4.xml","form_type":"4"}},{"id":419632,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-06T02:20:41.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":9786,"price":83.2879,"value":815055.3894,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $82.49 to $83.49.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":52952,"source":{"system":"sec-edgar","filing":"0001127602-18-004188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004188/form4.xml","form_type":"4"}},{"id":419631,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP,Corporate &Medical Affairs"}}],"security":"Common Stock","published_at":"2018-02-06T02:20:41.000Z","date":"2018-02-01","kind":"exercise","acquired":true,"shares":17250,"price":40.56,"value":699660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":62738,"source":{"system":"sec-edgar","filing":"0001127602-18-004188","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004188/form4.xml","form_type":"4"}},{"id":420505,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-01-16T22:42:42.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":18374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":90096,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":18374},"source":{"system":"sec-edgar","filing":"0001127602-18-001879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001879/form4.xml","form_type":"4"}},{"id":420504,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-01-16T22:42:42.000Z","date":"2018-01-11","kind":"exercise","acquired":false,"shares":7501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":7501},"source":{"system":"sec-edgar","filing":"0001127602-18-001879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001879/form4.xml","form_type":"4"}},{"id":420503,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-16T22:42:42.000Z","date":"2018-01-11","kind":"sale","acquired":false,"shares":4125,"price":79,"value":325875.0,"ownership":{"direct":true},"balance_after":45488,"source":{"system":"sec-edgar","filing":"0001127602-18-001879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001879/form4.xml","form_type":"4"}},{"id":420502,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-16T22:42:42.000Z","date":"2018-01-11","kind":"sale","acquired":false,"shares":18374,"price":79,"value":1451546.0,"ownership":{"direct":true},"balance_after":49613,"source":{"system":"sec-edgar","filing":"0001127602-18-001879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001879/form4.xml","form_type":"4"}},{"id":420501,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-16T22:42:42.000Z","date":"2018-01-11","kind":"sale","acquired":false,"shares":7501,"price":79,"value":592579.0,"ownership":{"direct":true},"balance_after":67987,"source":{"system":"sec-edgar","filing":"0001127602-18-001879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001879/form4.xml","form_type":"4"}},{"id":420500,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-16T22:42:42.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":18374,"price":40.56,"value":745249.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":75488,"source":{"system":"sec-edgar","filing":"0001127602-18-001879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001879/form4.xml","form_type":"4"}},{"id":420499,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-16T22:42:42.000Z","date":"2018-01-11","kind":"exercise","acquired":true,"shares":7501,"price":24.905,"value":186812.405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":57114,"source":{"system":"sec-edgar","filing":"0001127602-18-001879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001879/form4.xml","form_type":"4"}},{"id":420659,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-01-05T01:05:25.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":8625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":7501,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001127602-18-001218","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001218/form4.xml","form_type":"4"}},{"id":420658,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-05T01:05:25.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":5675,"price":73.8561,"value":419133.3675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $73.37 to $74.24.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":49613,"source":{"system":"sec-edgar","filing":"0001127602-18-001218","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001218/form4.xml","form_type":"4"}},{"id":420657,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-05T01:05:25.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":700,"price":72.3371,"value":50635.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $71.88 to $72.87.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":55288,"source":{"system":"sec-edgar","filing":"0001127602-18-001218","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001218/form4.xml","form_type":"4"}},{"id":420656,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-05T01:05:25.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":8625,"price":74,"value":638250.0,"ownership":{"direct":true},"balance_after":55988,"source":{"system":"sec-edgar","filing":"0001127602-18-001218","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001218/form4.xml","form_type":"4"}},{"id":420655,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2018-01-05T01:05:25.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":8625,"price":24.905,"value":214805.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":64613,"source":{"system":"sec-edgar","filing":"0001127602-18-001218","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001218/form4.xml","form_type":"4"}},{"id":421609,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-12-05T23:17:23.000Z","date":"2017-12-01","kind":"exercise","acquired":false,"shares":8625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":16126,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001127602-17-033980","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033980/form4.xml","form_type":"4"}},{"id":421608,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-12-05T23:17:23.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":3600,"price":75.1988,"value":270715.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transaction reported here range from $74.88 to $75.57. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":55988,"source":{"system":"sec-edgar","filing":"0001127602-17-033980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033980/form4.xml","form_type":"4"}},{"id":421607,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-12-05T23:17:23.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":11400,"price":74.4593,"value":848836.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transaction reported here range from $73.86 to $74.82. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request"}],"balance_after":59588,"source":{"system":"sec-edgar","filing":"0001127602-17-033980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033980/form4.xml","form_type":"4"}},{"id":421606,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-12-05T23:17:23.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":8625,"price":24.905,"value":214805.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":70988,"source":{"system":"sec-edgar","filing":"0001127602-17-033980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033980/form4.xml","form_type":"4"}},{"id":422520,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-11-03T22:59:06.000Z","date":"2017-11-01","kind":"exercise","acquired":false,"shares":8625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":24751,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001127602-17-031273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031273/form4.xml","form_type":"4"}},{"id":422519,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-11-03T22:59:06.000Z","date":"2017-11-01","kind":"sale","acquired":false,"shares":1600,"price":75.4831,"value":120772.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $75.25 to $75.73.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":62363,"source":{"system":"sec-edgar","filing":"0001127602-17-031273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031273/form4.xml","form_type":"4"}},{"id":422518,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-11-03T22:59:06.000Z","date":"2017-11-01","kind":"sale","acquired":false,"shares":13400,"price":74.7397,"value":1001511.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $74.22 to $75.21.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":63963,"source":{"system":"sec-edgar","filing":"0001127602-17-031273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031273/form4.xml","form_type":"4"}},{"id":422517,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-11-03T22:59:06.000Z","date":"2017-11-01","kind":"exercise","acquired":true,"shares":8625,"price":24.905,"value":214805.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":77363,"source":{"system":"sec-edgar","filing":"0001127602-17-031273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031273/form4.xml","form_type":"4"}},{"id":423065,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-10-04T23:26:20.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":33376,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001127602-17-029287","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029287/form4.xml","form_type":"4"}},{"id":423064,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-10-04T23:26:20.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":2141,"price":83.5211,"value":178818.6751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $83.315 to $83.62.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":68738,"source":{"system":"sec-edgar","filing":"0001127602-17-029287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029287/form4.xml","form_type":"4"}},{"id":423063,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-10-04T23:26:20.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":19938,"price":82.6779,"value":1648431.9702,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $82.31 to $83.26.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":70879,"source":{"system":"sec-edgar","filing":"0001127602-17-029287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029287/form4.xml","form_type":"4"}},{"id":423062,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-10-04T23:26:20.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":2921,"price":81.8406,"value":239056.3926,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $81.28 to $82.28.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":90817,"source":{"system":"sec-edgar","filing":"0001127602-17-029287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029287/form4.xml","form_type":"4"}},{"id":423061,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-10-04T23:26:20.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":17250,"price":24.905,"value":429611.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":93738,"source":{"system":"sec-edgar","filing":"0001127602-17-029287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029287/form4.xml","form_type":"4"}},{"id":423577,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-09-06T22:56:42.000Z","date":"2017-09-01","kind":"exercise","acquired":false,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":50626,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001127602-17-027101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027101/form4.xml","form_type":"4"}},{"id":423576,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-09-06T22:56:42.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":3737,"price":83.5449,"value":312207.2913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $83.32 to $84.05.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":76488,"source":{"system":"sec-edgar","filing":"0001127602-17-027101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027101/form4.xml","form_type":"4"}},{"id":423575,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-09-06T22:56:42.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":21263,"price":82.9601,"value":1763980.6063,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $82.31 to $83.31.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":80225,"source":{"system":"sec-edgar","filing":"0001127602-17-027101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027101/form4.xml","form_type":"4"}},{"id":423574,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-09-06T22:56:42.000Z","date":"2017-09-01","kind":"exercise","acquired":true,"shares":17250,"price":24.905,"value":429611.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":101488,"source":{"system":"sec-edgar","filing":"0001127602-17-027101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027101/form4.xml","form_type":"4"}},{"id":423669,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-09-01T21:15:34.000Z","date":"2017-08-30","kind":"exercise","acquired":false,"shares":21001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":21001},"source":{"system":"sec-edgar","filing":"0001127602-17-026845","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026845/form4.xml","form_type":"4"}},{"id":423668,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-09-01T21:15:34.000Z","date":"2017-08-30","kind":"exercise","acquired":false,"shares":22124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":67876,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":22124},"source":{"system":"sec-edgar","filing":"0001127602-17-026845","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026845/form4.xml","form_type":"4"}},{"id":423667,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-09-01T21:15:34.000Z","date":"2017-08-30","kind":"sale","acquired":false,"shares":50000,"price":79,"value":3950000.0,"ownership":{"direct":true},"balance_after":84238,"source":{"system":"sec-edgar","filing":"0001127602-17-026845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026845/form4.xml","form_type":"4"}},{"id":423666,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-09-01T21:15:34.000Z","date":"2017-08-30","kind":"exercise","acquired":true,"shares":21001,"price":26.99,"value":566816.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":134238,"source":{"system":"sec-edgar","filing":"0001127602-17-026845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026845/form4.xml","form_type":"4"}},{"id":423665,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Common Stock","published_at":"2017-09-01T21:15:34.000Z","date":"2017-08-30","kind":"exercise","acquired":true,"shares":22124,"price":24.905,"value":550998.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":113237,"source":{"system":"sec-edgar","filing":"0001127602-17-026845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217026845/form4.xml","form_type":"4"}},{"id":424349,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"officer":true,"officer_title":"EVP Comm&Acs ALA, Corp&Med Aff"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-08-03T22:58:30.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":8625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":21001,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001127602-17-024923","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217024923/form4.xml","form_type":"4"}}],"next_cursor":"2017-08-03T22:58:30.000000Z,424349"}